Melanoma Clinical Trial

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

Summary

The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

≥18 years of age.
Diagnosis of skin cancer.
Planning to initiate or already on ANY type of immunotherapy.
Able to provide urine and stool specimens.

Exclusion Criteria:

Bowel resection.
Major GI surgery in the past 5 years other than cholecystectomy and appendectomy.

Study is for people with:

Melanoma

Estimated Enrollment:

125

Study ID:

NCT03370861

Recruitment Status:

Recruiting

Sponsor:

Washington University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Barnes-Jewish Hosptial
Saint Louis Missouri, 63110, United States More Info
Research Study Coordinator
Contact
314-362-1000
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

125

Study ID:

NCT03370861

Recruitment Status:

Recruiting

Sponsor:


Washington University School of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.